Drs. Jack West, Mary Pinder, and Nate Pennell discuss options for managing acquired resistance to EGFR TKIs and ALK inhibitors in patients with advanced NSCLC and a driver mutation.
Podcast: Play in new windowDownload
You must be logged in to post a comment.
Subscribe toGRACE Notes (Free Newsletter)
Mission | Disclaimer